Home|Journals|Articles by Year|Audio Abstracts
 

Case Report

EJMCR. 2023; 7(7): 137-139


Kasabach-Merritt Syndrome: A Case Report of a Giant Hepatic Hemangioma in an Adult.

Arturo G. Rosales, Javier A. Martinez, Julio C. Ortiz-Cruz, Anabel M. Garcia, Dalia I. Murillo-Geraldo, Carlos A. Garcia-Becerra.




Abstract

Background: Hepatic Hemangioma (HH) is described as the most prevalent benign hepatic tumor, and it is usually discovered incidentally as a symptomless mass of less than 3 cm. Kasabach-Merritt Syndrome (KMS) is described as a rare but severe complication of some vascular tumors. This syndrome presents as severe thrombocytopenia accompanied with a consumptive coagulopathy.
Case presentation: A 35-year-old female, with a history of a hepatic tumor that was incidentally diagnosed with an ultrasound, later develops abdominal distention, petechiae and prominent hematomas that appear with minimal trauma. At the initial approach are found hematological data of microangiopathic anemia, thrombocytopenia and consumptive coagulopathy accompanied with the histopathological and imaging diagnosis of a Giant HH.
Conclusion: Although, it is a very rare complication, the severity of this Syndrome requires a prompt diagnosis and treatment.

Key words: Kasabach-Merritt Syndrome, Hepatic Hemangioma, Giant Hepatic Hemangioma, Thrombocytopenia, Disseminated Intravascular Coagulation, Case Report.






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.